Related Experiment Video

Updated: Aug 17, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

[Pharmacological regulation of opioidergic antinociceptive mechanisms]

V N Zhukov, Iu Iu Troian

    Biulleten' Eksperimental'Noi Biologii I Meditsiny
    |August 1, 1991
    PubMed

    Insights

    Certain non-opioidergic drugs can enhance morphine

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Pain Management

    Background:

    • Morphine's analgesic effects can be modulated by other compounds.
    • Understanding these interactions is crucial for optimizing pain relief.
    • Non-opioidergic compounds offer potential synergistic effects with opioids.

    Purpose of the Study:

    • To investigate the naloxone-dependent potentiation of morphine antinociception by various non-opioidergic drugs in mice.
    • To explore the mechanisms underlying this potentiation, including opioid receptor sensitivity, endogenous opioid release, and blood-brain barrier function.
    • To assess whether this potentiation affects respiratory depression and to evaluate the potential for developing novel combination analgesics.

    Main Methods:

    • Experiments were conducted on mice using nociceptive stimuli of different modalities.
    • The study examined the effects of co-administering morphine with various non-opioidergic compounds.
    • Naloxone was used to probe the opioid-dependent nature of the observed potentiation.

    Main Results:

    • Naloxone-dependent potentiation of morphine's antinociceptive effects was observed with several non-opioidergic compounds.
    • The mechanisms behind this potentiation remain complex and may involve opioid receptor sensitivity, endogenous opioid release, or altered blood-brain barrier permeability.
    • This potentiation, termed "release of functional reserve of opioid antinociceptive response," was not consistently associated with increased respiratory depression.

    Conclusions:

    • Non-opioidergic compounds can enhance morphine's pain-relieving properties through a naloxone-dependent mechanism.
    • The findings suggest a "release of functional reserve of opioid antinociceptive response," with potential dissociation from respiratory side effects.
    • This research supports the development of combination therapies combining opioids with specific non-opioidergic agents to improve analgesia and potentially reduce opioid-related risks.

    More Related Videos

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice07:09

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

    Published on: July 16, 2014

    Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

    Intracranial Pharmacotherapy and Pain Assays in Rodents

    Published on: April 9, 2019

    Related Concept Videos

    Nociception01:44

    Nociception

    Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
    Opioid Receptors: Overview01:22

    Opioid Receptors: Overview

    Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
    Analgesia and Pain Management01:25

    Analgesia and Pain Management

    Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
    Opioid Analgesics: Morphine and Other Natural Cogeners01:20

    Opioid Analgesics: Morphine and Other Natural Cogeners

    Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
    Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

    Opioid Analgesics: Synthetic and Semisynthetic Opioids

    Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
    Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

    Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

    Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
    Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...